SMARCAL1 and focal segmental glomerulosclerosis: They also observed that different SMARCAL1 gene mutations are associated with different types of FSGS, and that lesion progression or mutational variability affect clinical outcomes, thus furthering the understanding of FSGS in SIOD [59,63,64,65].